PhilipOPonceMD(He/Him)

Infectious Disease • Collegeville, PA

HIV/AIDS Medicine, Transplant/Immunocompromised States, STD Medicine

Assistant Director/Medical Monitor Pneumococcal Vaccines Pfizer VRD

Join to view full profile

Dr. Ponce is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ponce's full profile

Already have an account?

Office
500 Arcola Rd
Collegeville, PA 19426
Phone+1 210-567-7000

Clinical Expertise

Transplant infectious disease

Education & Training

Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2016 - 2018
University of California (San Francisco)Residency, Internal Medicine, 2006 - 2009
Perelman School of Medicine at the University of PennsylvaniaClass of 2006

Certifications & Licensure

CA State Medical License 2008 - 2024
TX State Medical License 2018 - 2024
MD State Medical License 2019 - 2019
MA State Medical License 2016 - 2018

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

Publications & Presentations

PubMed

63 citations
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.
Cameron R Wolfe, Kay M Tomashek, Thomas F Patterson, Carlos A Gomez, Vincent C Marconi
The Lancet. Respiratory Medicine. 2022-09-01
97 citations
Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phas...
Andre C. Kalil, Aneesh K. Mehta, Thomas F Patterson, Nathaniel B. Erdmann, Carlos A. Gomez
The Lancet. Respiratory Medicine. 2021-10-18
10 citations
Remdesivir for the prevention of invasive mechanical ventilation or death in COVID-19 - A post-hoc analysis of the Adaptive COVID-19 Treatment Trial-1 Cohort Data.
Catharine I. Paules, Shannon K. Gallagher, Rekha R. Rapaka, Richard T. Davey, Sarah B Doernberg
Clinical Infectious Diseases. 2021-08-11

Press Mentions

The Future of MonkeypoxNovember 28th, 2022
‘Desperate Need’: San Antonio Doctors Use COVID-Positive Donor Organs for Kidney, Liver TransplantsSeptember 2nd, 2022